
‘Enough to Hang Onto,' Says Canaccord About D-Wave Quantum Stock
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Still, even the hottest rallies take a pause. When the company released its Q2 results last week, investors appeared to see it as a moment to catch their breath, sending shares slightly lower in the aftermath.
The earnings snapshot was a mixed bag. Revenue came in at $3.1 million, up 42% year-over-year and beating expectations by $0.56 million. However, adjusted EPS showed a loss of $0.08, missing forecasts by $0.03. The miss was largely due to $142 million in non-cash, non-operating charges tied to the re-measurement of warrant liabilities and realized losses from warrant exercises.
Bookings painted a similar 'good news, but…' picture. At $1.3 million, they were up 92% from the same quarter last year, but slipped from $1.6 million in Q1. In fact, first-half 2025 bookings trail last year's pace.
Canaccord's Kingsley Crane isn't alarmed by that slowdown. The analyst points out that the comparison is skewed by the 'landmark' $18.3 million haul in 4Q24.
That's why, heading into the print, Crane was less focused on the headline numbers and more on management's pipeline commentary. Last quarter, D-Wave flagged several system deals in the works, noting their long sales cycles. This time, any evidence of an accelerating pipeline or quicker closures could help keep investor confidence intact.
'To that end,' Crane said, 'we think investors have enough to hang onto in terms of the potential acceleration of near-term system sale deal closures (namely, the MOU with Yonsei University International Campus in Songdo, Yeonsu-gu, Incheon, as well as some other un-named prospects) that they should be satisfied with the company's Q2 results.'
From a broader perspective, system sales are increasingly driving stock performance, and Crane has been assessing what that means going forward. Management still frames one system sale per year as the 'base case,' but CEO Alan Baratz hinted on the call that exceeding that pace is looking more likely. Even if the pace stays at one sale annually, rising average selling prices – boosted by the Advantage2 rollout – could push revenue higher. Meanwhile, QCaaS revenue may be poised for a rebound after likely bottoming in Q2.
'While we're waiting on the 10-Q, we think the Julich Advantage2 upgrade revenue recognition hit the P&L in Q2, and if you hold professional services flat, you get a meaningful decline in QCaaS qoq. With broad momentum in deployments across the business, we see Q2 as a likely trough for QCaaS,' Crane opines.
Bottom line, Crane assigns QBTS shares with a Buy rating and a $20 price target, suggesting an 18% upside from current levels. (To watch Crane's track record, click here)
The rest of Wall Street seems to agree: QBTS carries a Strong Buy consensus, backed by 11 unanimous Buy ratings, with an average target price of $22.18, implying a potential 31% gain in the year ahead. (See QBTS stock forecast)
To find good ideas for quantum stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
9 minutes ago
- Yahoo
Birkenstock profit beats estimates as shoemaker outlines plan to cope with tariffs
- Birkenstock (NYSE:BIRK) has posted better-than-anticipated profit in its fiscal third quarter and backed its full-year outlook, as the legacy German shoemaker said it is in a good spot despite the impact of elevated U.S. tariffs on the European Union. Known for its sandals and clogs, the more than 250-year old Birkenstock said it is "well-positioned" to handle President Donald Trump's increased 15% levies on many EU products sent to the U.S. -- a rate agreed upon by Washington and Brussels in late July. In a statement, CEO Oliver Reichert said the company will look to mitigate the duties through "a combination of pricing adjustment, cost discipline and inventory management." The firm backed its prior guidance for annual adjusted earnings before interest, taxes, depreciation and amortization margin of 31.3% to 31.8%. Analysts had seen the figure at 31.5%. At constant currency, revenue growth is also tipped to be at the "high end" of its predicted range of 15% to 17%. Operating profit in the three months ended on June 30 rose by 27% versus a year ago to 198 million euros, exceeding Bloomberg consensus projections of 182.7 million euros, with Reichert noting that income was bolstered by mid-single-digit expansion in average selling prices. Meanwhile, quarterly revenue increased by 12% to 635 million euros, compared with estimates of 636.3 million, as an uptick in business-to-business sales was offset by weaker-than-expected demand in the Americas region and at its direct-to-consumer segment. Shares of Birkenstock climbed by more than 3% in premarket U.S. trading on Thursday. Related articles Birkenstock profit beats estimates as shoemaker outlines plan to cope with tariffs If Powell goes, does Fed trust go with him? 7 Undervalued Stocks on the Rise With 50%+ Upside Potential Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
10 minutes ago
- Business Wire
KLC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against KinderCare Learning Companies, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of KinderCare Learning Companies, Inc. (NYSE: KLC) common stock in or traceable to KinderCare's October 2024 initial public offering ('IPO'), have until October 13, 2025 to seek appointment as lead plaintiff of the KinderCare class action lawsuit. Captioned Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424 (D. Or.), the KinderCare class action lawsuit charges KinderCare and certain of KinderCare's top executives and directors, KinderCare's controlling shareholder, and the underwriters of the IPO with violations of the Securities Act of 1933. If you suffered substantial losses and wish to serve as lead plaintiff of the KinderCare class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@ CASE ALLEGATIONS: KinderCare provides early education and child care services in the United States. In the IPO, KinderCare sold over 27 million shares of common stock to investors at $24 per share, raising $648 million in gross offering proceeds. The KinderCare class action lawsuit alleges that the registration statement for the IPO was false and/or misleading and/or failed to disclose that: (i) numerous incidents of child abuse, neglect, and harm had occurred at KinderCare facilities; (ii) KinderCare did not provide the 'highest quality care possible' at its facilities, and, indeed, in numerous instances had failed to provide even basic care, meet minimum standards in the child care industry, or comply with the laws and regulations governing the care of children; and (iii) as a result, KinderCare was exposed to a material, undisclosed risk of lawsuits, adverse regulatory action, negative publicity, reputational damage, and business loss. Since the IPO, the price of KinderCare stock fell to lows near $9 per share. The plaintiff is represented by Robbins Geller, which has extensive experience in prosecuting investor class actions including actions involving financial fraud. You can view a copy of the complaint by clicking here. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased KinderCare common stock in or traceable to the IPO to seek appointment as lead plaintiff in the KinderCare class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the KinderCare class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the KinderCare class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the KinderCare class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices.
Yahoo
19 minutes ago
- Yahoo
Why Vistra Stock Surged Almost 5% Higher on Tuesday
Key Points A pair of Vistra bulls published new takes on the company. These featured price target raises. 10 stocks we like better than Vistra › Electric utility Vistra (NYSE: VST) demonstrated some impressive power as a stock on Tuesday. The company's shares enjoyed a nearly 5% increase in price on the back of two price target increases from market professionals following the company's earnings release last week. That jump was well higher than the 1.1% rise of the S&P 500 index on the day. Two bulls go nuclear Both of the raising analysts are Vistra bulls, as evidenced by the fact that they maintained their respective equivalents of a buy recommendation. The first, Bank of America Securities's Ross Fowler, now believes Vistra could rise to $220 per share. That's up from his preceding level of $214. His peer James Thalacker of BMO Capital made a more dramatic raise, hiking his fair-value assessment to $229 per share from $191. According to reports, both analysts cited the second-quarter results Vistra posted last week as a key factor in their adjustments. Thalacker also pointed out that, per management's comments, there has been much interest in the operations of one of its nuclear power plants, Comanche Peak in Texas. Nuclear enjoys significant support from the Trump administration. In July 2024, Vistra received approval from the government's Nuclear Regulatory Commission to keep operating the plant through 2053. The second-quarter situation That second-quarter release featured some rather encouraging dynamics. For example, Vistra's operating revenue saw a nearly 11% year-over-year rise to $4.25 billion, although its GAAP net income fell to $327 million from the year-ago profit of $467 million. Should you invest $1,000 in Vistra right now? Before you buy stock in Vistra, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Vistra wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Bank of America is an advertising partner of Motley Fool Money. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Vistra Stock Surged Almost 5% Higher on Tuesday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data